New patients10% off your first order.

How to choose

How to choose a medical weight loss program in midlife

GLP-1 medicines have made medical weight loss widely available. The program around the prescription matters as much as the drug.

How to choose a medical weight loss program in midlife, HealifyMD How to choose

Who these medicines are for

FDA-approved weight management medicines are generally for adults with a body mass index of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or type 2 diabetes. NIDDK notes they work best combined with a lifestyle program and that people who have not lost at least 5 percent of their starting weight after 12 weeks on a full dose are often advised to stop.

A careful program checks these criteria and your medical history, instead of treating a prescription as a purchase.

Safety screening that should happen

GLP-1 medicines such as semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors seen in rodents, and they are not used in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Pancreatitis and gallbladder problems are other recognized risks, and these drugs are not used during pregnancy.

The most common side effects are digestive: nausea, vomiting, diarrhea, constipation and stomach pain. A good program starts at a low dose, increases slowly and tells you how to reach a clinician if symptoms are severe.

Branded versus compounded

Branded products such as Wegovy and Zepbound are FDA-approved. Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as the branded drugs. FDA has received reports of serious adverse events tied to dosing errors with compounded semaglutide and warns that salt forms such as semaglutide sodium have no lawful basis in compounding. It also warns against products labeled for research use only.

A trustworthy program tells you which kind you are getting, names the licensed pharmacy that fills it and gives clear dosing and storage instructions.

What good looks like

  • Medical eligibility confirmed, with a review of thyroid, pancreas, gallbladder and pregnancy considerations
  • Baseline labs where useful, such as A1c, lipids, kidney and liver function
  • Honest explanation of FDA-approved versus compounded options
  • Gradual dose increases and a plan for managing side effects
  • Advice on protein intake and strength training to help preserve muscle
  • Regular check-ins on weight, side effects and blood pressure or glucose medications that may need adjusting
  • A discussion of what happens when you stop or reduce the dose

Red flags

  • No questions about thyroid cancer history, pancreatitis or pregnancy
  • Products labeled for research use or not for human consumption
  • Vials that arrive warm, unlabeled or from an unnamed pharmacy
  • Promises of a specific number of pounds lost
  • Rapid dose escalation regardless of side effects
  • No guidance on nutrition, protein or exercise
  • Pressure to buy long packages before you know how you tolerate the medicine

Program structure: what support looks like

The medicine reduces appetite, but the habits you build during treatment are what carry you through maintenance. A useful program helps you plan meals with enough protein, fiber and fluids, manage nausea and constipation, keep up resistance training, and track measures beyond the scale, such as waist circumference, blood pressure and how your clothes fit.

Check-ins do not need to be weekly forever, but you should be able to reach a clinician when side effects flare and have scheduled reviews around dose changes. Programs should also coordinate with your other clinicians, especially if you take insulin or sulfonylureas for diabetes or blood pressure medications that may need to be lowered as weight falls.

Why midlife adds extra considerations

Weight loss after 45 can include meaningful muscle loss if protein intake and resistance training are neglected. Perimenopause and menopause, declining testosterone, poor sleep and medications can all affect weight. A program designed for midlife adults should ask about these and coordinate with any hormone therapy you are on.

Questions to ask

  • Am I medically eligible, and why?
  • Is this medication branded or compounded, and which pharmacy makes it?
  • How will you increase my dose, and what if I have side effects?
  • What should I eat and how should I train to protect muscle?
  • How often will I hear from a clinician?
  • What is the plan if I stop the medication?

Applying this to HealifyMD

You can apply every criterion above to HealifyMD. Compounded semaglutide injection is listed from $299 per month and compounded tirzepatide injection from $399 per month; these are not FDA-approved and are not the same as Wegovy or Zepbound. Members using branded GLP-1s can join the weight loss program membership for $75 per month. Prices are confirmed during your eligibility review, and labs are priced separately.

Common questions

Am I eligible for a GLP-1 medicine?

Generally, FDA-approved weight management medicines are for adults with a BMI of 30 or more, or 27 or more with a weight-related condition. A clinician also reviews your history for reasons the drug would be unsafe.

Is compounded semaglutide the same as Wegovy?

No. Compounded semaglutide is not FDA-approved, and FDA has not reviewed it for safety, effectiveness or quality.

What side effects are most common?

Nausea, vomiting, diarrhea, constipation and stomach pain are the most common. They often improve as the body adjusts and with slow dose increases.

Will I lose muscle on a GLP-1?

Some of the weight lost can be muscle. Adequate protein and regular strength training help limit that.

What happens when I stop?

Many people regain some weight after stopping. A good program plans for this, including maintenance strategies and, when appropriate, a lower dose.

Should I buy GLP-1s labeled for research use?

No. FDA warns that research-use-only products sold for people have unknown quality and may be harmful.

Sources

We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.

  1. Prescription medications to treat overweight and obesityNational Institute of Diabetes and Digestive and Kidney Diseases
  2. FDA's concerns with unapproved GLP-1 drugs used for weight lossU.S. Food and Drug Administration
  3. Semaglutide injectionMedlinePlus (National Library of Medicine)
  4. Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration

Find out what your body needs next

Start with a free eligibility check. A licensed clinician reviews your history and goals, and recommends labs or treatment only if they fit.

  • No membership fee
  • Licensed clinicians
  • 100% online